Exam 3 - Thrombosis Flashcards
VTE treatment - UFH regular IV dosing
80 U/kg IV bolus followed by 18 U/kg/hr iV infusion
VTE treatment - UFH regular subQ dosing
initial dose of 333 U/kg subQ, followed by 250 U/kg subQ q12hrs
UFH renal adjustments
None
Is monitoring required for both IV and subQ UFH treatment?
No, only required for IV treatment
monitoring parameters for UFH IV treatment
aPTT 6 hrs after bolus and each dose adjustment OR anti-Xa activity for pts with excess factor VII or large doses
target range for aPTT
1.5-2.5x the normal value
VTE treatment - enoxaparin regular dosing
1 mg/kg subQ q12hrs OR 1.5 mg/kg subQ q24hrs
VTE treatment -
enoxaparin renal adjustments
For CrCl < 30 mL/min, 1 mg/kg q24hrs subQ
monitoring parameters for enoxaparin
anti-Xa activity for pregnant pts, burn pts, severe renal impairment, pts with extreme weights (< 50 kg/> 190 kg), prolonged therapy
VTE treatment - dalteparin regular dosing
100 U/kg subQ q12hrs OR 200 U/kg subQ q24hrs
dalteparin renal adjustments
None
What is the regular dosing for fondaparinux in VTE treatment?
< 50 kg = 5 mg subQ q24hrs
50-100 kg = 7.5 mg subQ q24hrs
> 100 kg = 10 mg subQ q24hrs
What renal adjustments are required with fondaparinux treatment?
CI for CrCl < 30 mL/min
What monitoring parameter are required for fondaparinux treatment?
anti-Xa activity
What is the regular dosing for apixaban in VTE treatment?
10 mg PO q12hrs for 7 days, followed by 5 mg PO q12hrs